Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Building a R&D strategy for the modern age
Low levels of return on investment in R&D is an issue that has been bubbling beneath the surface of pharmaceutical companies for some time and the situation is coming to a head, threatening the industry’s future
Creating the patient-centred trial
Patient recruitment and retention remain the biggest challenges in clinical studies, it is surely time for industry to trial a new approach.
The history of medical affairs
Learn about the origins of the medical affairs function, how far it’s come and where it may be heading in the future as key proprietor of patient centricity.
Ipsen’s Isabelle Bocher-Pianka on patient-centric pharma evolution
Isabelle Bocher-Pianka, Chief Patient Affairs Officer, Global Medical Affairs, Ipsen shares her thoughts on pharma’s mission to help improve patient lives, challenges that hinder patient centricity and seeking knowledge across industries.
Pharma: the social butterfly
The internet is a jungle, tangled and overgrown, dense with information overload. Among the unkempt chaos lies social media: a treasure trove of possibilities for the pharmaceutical industry.
27th November 2019
ESC 2019 – Interview – Dr Çetin Erol
An interview with Dr Çetin Erol, İbn-i Sina Hospital, Faculty of Medicine, Department of Cardiology, Ankara University, Ankara, Turkey, at this year’s ESC…
1
Mins
26th November 2019
Will NASA Exercise Programmes Astronomically Improve Chemotherapy Patient Fitness?
Astronauts experience physical stress while in space and have a rigorous training programme prior, during, and after their expedition…
1
Mins
26th November 2019
New Method to More Accurately Estimate Breast Cancer Survival Rates
Survival rates for those with later-stage cancer are progressively increasing with better treatment and earlier diagnosis…
9
Mins
26th November 2019
Psoriasis and Atopic Dermatitis: Addressing Therapeutic Paradigms by Learning from Each Other
Psoriasis and AD are chronic, systemic inflammatory diseases of the skin characterised by upregulation of proinflammatory cytokines…
9
Mins
26th November 2019
Editor's Pick: Acne Therapy Across Time in the USA
Acne is the most common skin condition in the USA, affecting over half of its population.1 It is an inflammatory skin disease that predominantly…
←
1
2
3
…
531
532
533
534
535
536
537
…
911
912
913
→